Hace casi un año se aprobó un fármaco para frenar el alzhéimer. ¿Ha funcionado?news2024-06-17T21:59:44+00:00June 17th, 2024|The New York Times|
How A.I. Is Revolutionizing Drug Developmentnews2024-06-17T09:03:08+00:00June 17th, 2024|The New York Times|
Akira Endo, Scholar of Statins That Reduce Heart Disease, Dies at 90news2024-06-13T02:44:32+00:00June 13th, 2024|The New York Times|
FDA Advisory Panel Endorses Approval of Alzheimer’s Drug Made by Eli Lillynews2024-06-10T21:05:19+00:00June 10th, 2024|The New York Times|
Leqembi and Alzheimer’s: What to Know About the New Drug, Treatment and Benefitsnews2024-06-10T09:00:35+00:00June 10th, 2024|The New York Times|
FDA Panel Rejects Use of MDMA for Treatment of PTSDnews2024-06-04T23:06:17+00:00June 4th, 2024|The New York Times|
What Are the MDMA Risks of Therapy for PTSD?news2024-06-04T22:12:47+00:00June 4th, 2024|The New York Times|
